ImmunoGen, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (44)

Latest Posts

About This Stock More About This Stock
ABBV: This Top Biotech Just Went On A Buying Spree
Article By: Tony Daltorio
Thursday, January 25, 2024 7:00 AM EDT
AbbVie stock is a buy following its recent merger & acquisition activity (Immunogen and Cerevel).
In this article: ABBV Also: IMGN, AMGN, CERE, KRTX
Read
How To Invest In The Healthcare Sector
Article By: Marc Lichtenfeld
Saturday, August 19, 2023 12:39 PM EDT
If things go wrong with some healthcare companies, investors often justify why they stay in the stock. And when things go right, they can go right in a hurry. Mersana Therapeutics is an example of how biotech stocks can experience these big swings.
In this article: MRSN Also: TGT, IMGN, SGEN
Read
Stocks Stumble, Weekly Wins Still In Sight
Article By: Schaeffers Research
Friday, May 19, 2023 12:16 PM EDT
Stocks are lower midday, paring solid gains from the morning. Despite stumbling into the weekend, all three major indexes are heading toward comfy weekly wins.
In this article: FL, IMGN, QQQ, SPX, VIX, DJI, CTLT
Read
Stocks Mixed Ahead Of Fed Policy Decision
Article By: Schaeffers Research
Wednesday, May 3, 2023 12:18 PM EDT
Stocks are mixed this afternoon, albeit muted, as investors await the conclusion of the Fed's two-day policy meeting.
In this article: EL, IMGN, QQQ, SPX, VIX, DJI, CHGG
Read
Week In Review: Boston Scientific Pays $523 Million For Majority Stake In Beijing Acotec Scientific
Article By: ChinaBio® Today
Saturday, December 17, 2022 1:00 PM EDT
Boston Scientific will pay $523 million for a 65% stake in Acotec Scientific, a Beijing medical device company. Boston Scientific said the acquisition will build up its presence in China, and it will also bring Acotec’s products to western markets.
In this article: BSX Also: PRE, IMGN, BGNE, IVBXF
Read

Latest Tweets for $IMGN

No tweets yet!

PARTNER HEADLINES